Virax Biolabs Group (VRAX) Stock Chart & Stock Price History → Biden to Drop BOMBSHELL June 13th? (From Paradigm Press) (Ad) Free VRAX Stock Alerts $0.76 -0.04 (-5.03%) (As of 05/14/2024 ET) Add Compare Share Share ChartStock AnalysisChartCompetitorsFinancialsHeadlinesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisChartCompetitorsFinancialsHeadlinesOwnershipSEC FilingsShort InterestSocial Media Virax Biolabs Group Stock Price Performance5 Day Performance+9.42%1 Month Performance+2.03%3 Month Performance-5.64%6 Month Performance-68.54%Year-To-Date Performance-48.29%1 Year Performance-78.61% Receive VRAX Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Virax Biolabs Group and its competitors with MarketBeat's FREE daily newsletter Email Address Ad InvestorPlaceElon Musk’s Next Move Will Disrupt AI ForeverA revolutionary venture that is set to get rolled out by May 16. One well-connected Silicon Valley VC has uncovered a way for anybody to claim a stake in "Elon Musk's AI 2.0" with as little as $100.Get all the information here. VRAX Stock Chart for Tuesday, May, 14, 2024 VRAX Chart by TradingView Virax Biolabs Group Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization05/14/2024$0.79$0.76-4.83%$0.83$0.7437,222 shs$1.17 million05/13/2024$0.80$0.79-0.84%$0.82$0.7761,463 shs$1.23 million05/10/2024$0.69$0.80+15.94%$0.81$0.7073,910 shs$1.24 million05/09/2024$0.79$0.69-12.55%$0.79$0.6917,006 shs$1.07 million05/08/2024$0.73$0.79+8.08%$0.79$0.7330,666 shs$1.23 million05/07/2024$0.65$0.73+13.18%$0.84$0.65146,629 shs$1.14 million Get the Latest News and Ratings for VRAX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Virax Biolabs Group and its competitors with MarketBeat's FREE daily newsletter. 05/06/2024$0.61$0.65+5.07%$0.67$0.613,675 shs$1 million05/03/2024$0.61$0.61+0.64%$0.63$0.6029,397 shs$952,000.0005/02/2024$0.67$0.61-8.82%$0.67$0.619,439 shs$949,000.0005/01/2024$0.63$0.67+6.19%$0.67$0.6053,780 shs$1.04 million04/30/2024$0.63$0.63+0.21%$0.68$0.6312,785 shs$976,000.0004/29/2024$0.69$0.63-8.89%$0.71$0.6218,210 shs$974,000.0004/26/2024$0.70$0.69-1.43%$0.73$0.673,036 shs$1.07 million04/25/2024$0.65$0.70+7.53%$0.70$0.668,482 shs$1.09 million04/24/2024$0.66$0.65-1.06%$0.66$0.631,895 shs$1.01 million04/23/2024$0.68$0.66-3.24%$0.74$0.6139,713 shs$1.02 million04/22/2024$0.68$0.68+0.41%$0.71$0.685,284 shs$1.05 million04/19/2024$0.68$0.68+0.34%$0.74$0.648,234 shs$1.06 million04/18/2024$0.69$0.68-1.19%$0.74$0.684,769 shs$1.07 million04/17/2024$0.65$0.69+5.73%$0.78$0.6521,218 shs$1.07 million04/16/2024$0.68$0.65-3.61%$0.69$0.636,249 shs$1.01 million04/15/2024$0.74$0.68-8.78%$0.74$0.6157,610 shs$1.05 million04/12/2024$0.78$0.77-1.41%$0.82$0.7134,166 shs$1.19 million04/11/2024$0.78$0.78$0.83$0.777,306 shs$1.21 million04/10/2024$0.77$0.78+1.30%$0.82$0.765,138 shs$1.21 million04/09/2024$0.84$0.77-8.28%$0.81$0.7511,078 shs$1.20 million04/08/2024$0.82$0.84+2.38%$0.84$0.7910,866 shs$1.30 million04/05/2024$0.82$0.82-0.12%$0.88$0.8023,366 shs$1.27 million04/04/2024$0.87$0.82-5.63%$0.90$0.8160,482 shs$1.28 million04/03/2024$0.78$0.87+10.94%$0.89$0.7996,558 shs$1.35 million04/02/2024$0.74$0.78+6.69%$0.84$0.7236,700 shs$1.22 million04/01/2024$0.72$0.74+2.51%$0.79$0.7113,018 shs$1.14 million03/29/2024$0.72$0.72$0.78$0.719,360 shs$1.12 million03/28/2024$0.71$0.72+1.70%$0.78$0.719,315 shs$1.11 million03/27/2024$0.75$0.71-6.00%$0.80$0.7020,702 shs$1.09 million03/26/2024$0.75$0.75$0.80$0.7423,252 shs$1.16 million03/25/2024$0.78$0.75-3.85%$0.80$0.7519,640 shs$1.16 million03/22/2024$0.78$0.79+0.81%$0.81$0.7711,046 shs$1.22 million03/21/2024$0.79$0.78-1.66%$0.83$0.7714,700 shs$1.21 million03/20/2024$0.81$0.79-2.13%$0.86$0.7720,864 shs$1.23 millionLook Who Fired the World’s Richest Man (Ad)This company is tiny… but already has contracts with 30 federal agencies and services some of the biggest companies in the U.S. And demand for the technology is unprecedented … “unlike anything we have seen in the past,” says a spokesman.Get the full story here.03/19/2024$0.84$0.81-3.40%$0.81$0.813,092 shs$1.26 million03/18/2024$0.84$0.84+0.36%$0.88$0.8312,042 shs$1.30 million03/15/2024$0.85$0.85-0.51%$0.88$0.8131,775 shs$1.31 million03/14/2024$0.85$0.85$0.89$0.844,721 shs$1.32 million03/13/2024$0.87$0.85-1.97%$0.90$0.8525,381 shs$1.32 million03/12/2024$0.87$0.87-0.33%$0.91$0.8715,546 shs$1.34 million03/11/2024$0.89$0.87-2.25%$0.93$0.8726,465 shs$1.35 million03/08/2024$0.95$0.90-4.79%$0.97$0.8781,093 shs$1.40 million03/07/2024$0.98$0.95-3.54%$1.01$0.9360,931 shs$1.47 million03/06/2024$0.98$0.98$1.04$0.9560,322 shs$1.52 million03/05/2024$0.97$0.98+1.03%$1.04$0.9849,984 shs$1.52 million03/04/2024$1.00$0.97-3.00%$1.04$0.9278,276 shs$1.50 million03/01/2024$0.96$1.00+3.90%$1.09$0.95254,539 shs$1.55 million02/29/2024$0.96$0.96+0.27%$0.99$0.9438,122 shs$1.49 million02/28/2024$0.93$0.96+3.18%$0.97$0.9129,276 shs$1.49 million02/27/2024$0.94$0.93-0.56%$0.98$0.9147,885 shs$1.44 million02/26/2024$0.89$0.94+5.63%$0.97$0.8830,610 shs$1.45 million02/23/2024$0.89$0.89-0.48%$0.98$0.8766,977 shs$1.37 million02/22/2024$0.96$0.89-7.71%$0.98$0.8667,374 shs$1.38 million02/21/2024$0.83$0.96+15.90%$0.98$0.85115,510 shs$1.50 million02/20/2024$0.82$0.83+1.48%$0.84$0.8125,882 shs$1.29 million02/19/2024$0.82$0.82$0.83$0.7940,500 shs$1.27 million02/16/2024$0.82$0.82-0.27%$0.83$0.7940,502 shs$1.27 million02/15/2024$0.80$0.82+2.75%$0.83$0.8013,042 shs$1.28 million02/14/2024$0.83$0.80-3.44%$0.85$0.7923,790 shs$1.24 million02/13/2024$0.86$0.83-3.63%$0.85$0.7748,812 shs$1.28 million Related Companies: Navidea Biopharmaceuticals Stock Chart Acorda Therapeutics Stock Chart 9 Meters Biopharma Stock Chart Sunshine Biopharma Stock Chart Sintx Technologies Stock Chart GRI Bio Stock Chart Biodexa Pharmaceuticals Stock Chart Panbela Therapeutics Stock Chart Bone Biologics Stock Chart Nemaura Medical Stock Chart Receive VRAX Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Virax Biolabs Group and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:VRAX) was last updated on 5/14/2024 by MarketBeat.com Staff From Our PartnersDid Intel Just Dethrone Nvidia?Chaikin AnalyticsAmerica’s worst nightmare?Porter & CompanyInvest Now: Starpax's Cancer Breakthrough Achieving What Others Haven't for a CenturyStarpaxRevolutionizing the Green Energy Space and Building Shareholder Value Along the WaySmall Cap SniperHow to Make 100X on the AI BoomInvestorPlaceTech GIANT’s Plans to Revolutionize Crypto…Crypto 101 MediaClaim Your Complimentary Bitcoin RewardCrypto Swap ProfitsForget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THISParadigm Press Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Virax Biolabs Group Limited Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.